LFTD Partners Inc.

LIFD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $8.7M $9.2M $8.4M $9.1M $10.3M $9.1M $8.5M $8.7M
Cost of Revenue $8.1M $10.9M $5.4M $4.9M $7.1M $6.9M $6.4M $4.9M
Gross Profit $651.2K $-1.7M $3.0M $4.2M $3.2M $2.2M $2.1M $3.8M
Gross Margin 7.5% -18.6% 35.6% 45.9% 31.4% 24.3% 24.3% 43.2%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense — — — — — — — —
Operating Income $-1.5M $-4.6M $38.4K $1.3M $-109.6K $-328.4K $72.3K $-140.7K
Operating Margin -17.5% -49.8% 0.5% 14.5% -1.1% -3.6% 0.9% -1.6%
Interest Expense $21.8K $21.2K — — $77.5K $80.0K — $88.3K
Pretax Income $-1.6M $-4.7M $-24.6M $870.8K $-323.8K $-382.8K $3.9K $-189.1K
Income Tax Expense $-206.7K $-555.1K $330.8K $236.6K $-54.8K $-79.7K $2.7K $5.3K
Net Income $-1.4M $-4.2M $-24.9M $634.3K $-269.0K $-303.0K $1.2K $-194.4K
Net Margin -16.5% -45.4% -296.2% 7.0% -2.6% -3.3% 0.0% -2.2%
EPS (Basic) $-0.10 $-0.28 $-1.68 $0.04 $-0.02 $-0.02 $0.00 $-0.01
EPS (Diluted) $-0.10 $-0.28 $-1.68 $0.04 $-0.02 $-0.02 $0.00 $-0.01
Shares Outstanding (Basic) 14.8M 14.8M 14.8M 14.8M 14.8M 14.8M 14.8M 14.8M
Shares Outstanding (Diluted) 14.8M 14.8M 14.8M 15.0M 14.8M 14.8M 14.8M 14.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 5 Older →